RankAlpha logo
Back to Rankings

NBTX

NanobiotixF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Positive pivotal/clinical outcomes and a clear regulatory path drive rapid re-rating; partnerships or licensing could accelerate adoption.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta 0.0.
What can break
Failed pivotal trial or negative clinical data
Momentum
65
Value
46
Sentiment
13
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $21.53 · Bull $32.30 · Bear $8.61Analysis 2026-01-16; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-16 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-09-09

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions

Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $54.95
Why
Momentum65 · Δ7d +1.4
Value46 · Δ7d 0.0
Sentiment13 · Δ7d +4.6
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • Value remains the lead driver in the composite, 7D delta 0.0.

Contradictions & invalidation

  • Failed pivotal trial or negative clinical data
  • Funding needs / equity dilution
  • Failed readouts, prolonged regulatory uncertainty, or dilutive financing materially reduce equity value and push shares toward the low end of published targets.

Catalyst clock

2026-04-16

Analyst updates / consensus revisions

Lead driver: Value · See fundamentals
Momentum
65
9% active weight
Current posture
7d trendImproving
Δ7d
+1.4
Δ21d
-12.7
Value
46
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-0.0
Sentiment
13
62% active weight
Current posture
7d trendImproving
Δ7d
+4.6
Δ21d
+7.4
Why this grade

Composite grade F. Momentum 64.5 / Value 46.5 / Sentiment 13.0

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-16. Scenario method

B+
Bull case
25%
Probability
Target price
$32.30
Analysis reference price unavailable
Analysis 2026-01-16 · RankAlpha Sentiment AI
Most likely
B
Base case
55%
Probability
Target price
$21.53
Analysis reference price unavailable
Analysis 2026-01-16 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$8.61
Analysis reference price unavailable
Analysis 2026-01-16 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$2.08B
Beta
0.18
Shares Out
50.6M
P/E (TTM) · Derived
-72.6
P/S (TTM)
89.51
P/FCF (TTM) · Derived
-47.55
Rev YoY
-39.5%
EPS YoY
+75.5%
Gross Margin
-35.7%
Op Margin
-49.1%
Net Debt
$50M
Current Ratio
1.09
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data